UK Markets open in 6 hrs 10 mins
  • NIKKEI 225

    28,288.75
    +319.76 (+1.14%)
     
  • HANG SENG

    19,129.92
    +532.69 (+2.86%)
     
  • CRUDE OIL

    80.62
    +0.07 (+0.09%)
     
  • GOLD FUTURES

    1,789.80
    +29.90 (+1.70%)
     
  • DOW

    34,589.77
    +737.24 (+2.18%)
     
  • BTC-GBP

    14,178.03
    +168.45 (+1.20%)
     
  • CMC Crypto 200

    406.26
    +5.57 (+1.39%)
     
  • Nasdaq

    11,468.00
    +484.22 (+4.41%)
     
  • ^FTAS

    4,139.65
    +27.35 (+0.67%)
     

Global Up-Regulated Protein Market to Reach $664.3 Million by 2027

ReportLinker
ReportLinker

In the changed post COVID-19 business landscape, the global market for Up-Regulated Protein estimated at US$460. 7 Million in the year 2020, is projected to reach a revised size of US$664. 3 Million by 2027, growing at a CAGR of 5.

New York, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Up-Regulated Protein Industry" - https://www.reportlinker.com/p06033198/?utm_source=GNW
4% over the analysis period 2020-2027. Diagnostic Labs, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$242.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Outpatient Clinics segment is readjusted to a revised 5.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $125.5 Million, While China is Forecast to Grow at 9.6% CAGR

The Up-Regulated Protein market in the U.S. is estimated at US$125.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$146.7 Million by the year 2027 trailing a CAGR of 9.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$91.4 Million by the year 2027.



Hospitals Segment to Record 4.9% CAGR

In the global Hospitals segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$86.7 Million in the year 2020 will reach a projected size of US$118.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 5.4% CAGR through the analysis period.

Select Competitors (Total 33 Featured) -
Alpavit
Arla Foods
Carbery Group
Davisco Foods International, Inc.
Fonterra Co-operative Group Ltd
Glanbia plc
Hilmar Cheese Company, Inc.
LACTALIS Ingredients
Leprino Foods Company
Maple Island Inc.


Read the full report: https://www.reportlinker.com/p06033198/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Up-Regulated Protein - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Up-Regulated Protein by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Up-Regulated Protein by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Up-Regulated Protein by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Diagnostic Labs by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Diagnostic Labs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Diagnostic Labs by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Outpatient Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Outpatient Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Outpatient Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Research Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Research Centers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Research Centers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 16: World Up-Regulated Protein Market Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2027

III. MARKET ANALYSIS

UNITED STATES
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 17: USA Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 18: USA Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 19: USA 15-Year Perspective for Up-Regulated Protein by
End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

CANADA
Table 20: Canada Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 21: Canada Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 22: Canada 15-Year Perspective for Up-Regulated Protein
by End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

JAPAN
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Table 23: Japan Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 24: Japan Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 25: Japan 15-Year Perspective for Up-Regulated Protein by
End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

CHINA
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 26: China Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 27: China Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 28: China 15-Year Perspective for Up-Regulated Protein by
End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

EUROPE
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Table 29: Europe Recent Past, Current & Future Analysis for
Up-Regulated Protein by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 30: Europe Historic Review for Up-Regulated Protein by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 31: Europe 15-Year Perspective for Up-Regulated Protein
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027

Table 32: Europe Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 33: Europe Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 34: Europe 15-Year Perspective for Up-Regulated Protein
by End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

FRANCE
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 35: France Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 36: France Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 37: France 15-Year Perspective for Up-Regulated Protein
by End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

GERMANY
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 38: Germany Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 39: Germany Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 40: Germany 15-Year Perspective for Up-Regulated Protein
by End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

ITALY
Table 41: Italy Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 42: Italy Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 43: Italy 15-Year Perspective for Up-Regulated Protein by
End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

UNITED KINGDOM
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2022 (E)
Table 44: UK Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 45: UK Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 46: UK 15-Year Perspective for Up-Regulated Protein by
End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

SPAIN
Table 47: Spain Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 48: Spain Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 49: Spain 15-Year Perspective for Up-Regulated Protein by
End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

RUSSIA
Table 50: Russia Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 51: Russia Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 52: Russia 15-Year Perspective for Up-Regulated Protein
by End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

REST OF EUROPE
Table 53: Rest of Europe Recent Past, Current & Future Analysis
for Up-Regulated Protein by End-Use - Diagnostic Labs,
Outpatient Clinics, Hospitals and Research Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 54: Rest of Europe Historic Review for Up-Regulated
Protein by End-Use - Diagnostic Labs, Outpatient Clinics,
Hospitals and Research Centers Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 55: Rest of Europe 15-Year Perspective for Up-Regulated
Protein by End-Use - Percentage Breakdown of Value Sales for
Diagnostic Labs, Outpatient Clinics, Hospitals and Research
Centers for the Years 2012, 2021 & 2027

ASIA-PACIFIC
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Table 56: Asia-Pacific Recent Past, Current & Future Analysis
for Up-Regulated Protein by Geographic Region - Australia,
India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 57: Asia-Pacific Historic Review for Up-Regulated Protein
by Geographic Region - Australia, India, South Korea and Rest
of Asia-Pacific Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 58: Asia-Pacific 15-Year Perspective for Up-Regulated
Protein by Geographic Region - Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2021 & 2027

Table 59: Asia-Pacific Recent Past, Current & Future Analysis
for Up-Regulated Protein by End-Use - Diagnostic Labs,
Outpatient Clinics, Hospitals and Research Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 60: Asia-Pacific Historic Review for Up-Regulated Protein
by End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 61: Asia-Pacific 15-Year Perspective for Up-Regulated
Protein by End-Use - Percentage Breakdown of Value Sales for
Diagnostic Labs, Outpatient Clinics, Hospitals and Research
Centers for the Years 2012, 2021 & 2027

AUSTRALIA
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Australia for 2022 (E)
Table 62: Australia Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 63: Australia Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 64: Australia 15-Year Perspective for Up-Regulated
Protein by End-Use - Percentage Breakdown of Value Sales for
Diagnostic Labs, Outpatient Clinics, Hospitals and Research
Centers for the Years 2012, 2021 & 2027

INDIA
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in India for 2022 (E)
Table 65: India Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 66: India Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 67: India 15-Year Perspective for Up-Regulated Protein by
End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

SOUTH KOREA
Table 68: South Korea Recent Past, Current & Future Analysis
for Up-Regulated Protein by End-Use - Diagnostic Labs,
Outpatient Clinics, Hospitals and Research Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 69: South Korea Historic Review for Up-Regulated Protein
by End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 70: South Korea 15-Year Perspective for Up-Regulated
Protein by End-Use - Percentage Breakdown of Value Sales for
Diagnostic Labs, Outpatient Clinics, Hospitals and Research
Centers for the Years 2012, 2021 & 2027

REST OF ASIA-PACIFIC
Table 71: Rest of Asia-Pacific Recent Past, Current & Future
Analysis for Up-Regulated Protein by End-Use - Diagnostic Labs,
Outpatient Clinics, Hospitals and Research Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 72: Rest of Asia-Pacific Historic Review for Up-Regulated
Protein by End-Use - Diagnostic Labs, Outpatient Clinics,
Hospitals and Research Centers Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 73: Rest of Asia-Pacific 15-Year Perspective for
Up-Regulated Protein by End-Use - Percentage Breakdown of Value
Sales for Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers for the Years 2012, 2021 & 2027

LATIN AMERICA
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Latin America for 2022 (E)
Table 74: Latin America Recent Past, Current & Future Analysis
for Up-Regulated Protein by Geographic Region - Argentina,
Brazil, Mexico and Rest of Latin America Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 75: Latin America Historic Review for Up-Regulated
Protein by Geographic Region - Argentina, Brazil, Mexico and
Rest of Latin America Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 76: Latin America 15-Year Perspective for Up-Regulated
Protein by Geographic Region - Percentage Breakdown of Value
Sales for Argentina, Brazil, Mexico and Rest of Latin America
Markets for Years 2012, 2021 & 2027

Table 77: Latin America Recent Past, Current & Future Analysis
for Up-Regulated Protein by End-Use - Diagnostic Labs,
Outpatient Clinics, Hospitals and Research Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 78: Latin America Historic Review for Up-Regulated
Protein by End-Use - Diagnostic Labs, Outpatient Clinics,
Hospitals and Research Centers Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 79: Latin America 15-Year Perspective for Up-Regulated
Protein by End-Use - Percentage Breakdown of Value Sales for
Diagnostic Labs, Outpatient Clinics, Hospitals and Research
Centers for the Years 2012, 2021 & 2027

ARGENTINA
Table 80: Argentina Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 81: Argentina Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 82: Argentina 15-Year Perspective for Up-Regulated
Protein by End-Use - Percentage Breakdown of Value Sales for
Diagnostic Labs, Outpatient Clinics, Hospitals and Research
Centers for the Years 2012, 2021 & 2027

BRAZIL
Table 83: Brazil Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 84: Brazil Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 85: Brazil 15-Year Perspective for Up-Regulated Protein
by End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

MEXICO
Table 86: Mexico Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 87: Mexico Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 88: Mexico 15-Year Perspective for Up-Regulated Protein
by End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

REST OF LATIN AMERICA
Table 89: Rest of Latin America Recent Past, Current & Future
Analysis for Up-Regulated Protein by End-Use - Diagnostic Labs,
Outpatient Clinics, Hospitals and Research Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 90: Rest of Latin America Historic Review for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 91: Rest of Latin America 15-Year Perspective for
Up-Regulated Protein by End-Use - Percentage Breakdown of Value
Sales for Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers for the Years 2012, 2021 & 2027

MIDDLE EAST
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Middle East for 2022 (E)
Table 92: Middle East Recent Past, Current & Future Analysis
for Up-Regulated Protein by Geographic Region - Iran, Israel,
Saudi Arabia, UAE and Rest of Middle East Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 93: Middle East Historic Review for Up-Regulated Protein
by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest
of Middle East Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 94: Middle East 15-Year Perspective for Up-Regulated
Protein by Geographic Region - Percentage Breakdown of Value
Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle
East Markets for Years 2012, 2021 & 2027

Table 95: Middle East Recent Past, Current & Future Analysis
for Up-Regulated Protein by End-Use - Diagnostic Labs,
Outpatient Clinics, Hospitals and Research Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 96: Middle East Historic Review for Up-Regulated Protein
by End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 97: Middle East 15-Year Perspective for Up-Regulated
Protein by End-Use - Percentage Breakdown of Value Sales for
Diagnostic Labs, Outpatient Clinics, Hospitals and Research
Centers for the Years 2012, 2021 & 2027

IRAN
Table 98: Iran Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 99: Iran Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 100: Iran 15-Year Perspective for Up-Regulated Protein by
End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

ISRAEL
Table 101: Israel Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 102: Israel Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 103: Israel 15-Year Perspective for Up-Regulated Protein
by End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

SAUDI ARABIA
Table 104: Saudi Arabia Recent Past, Current & Future Analysis
for Up-Regulated Protein by End-Use - Diagnostic Labs,
Outpatient Clinics, Hospitals and Research Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 105: Saudi Arabia Historic Review for Up-Regulated
Protein by End-Use - Diagnostic Labs, Outpatient Clinics,
Hospitals and Research Centers Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 106: Saudi Arabia 15-Year Perspective for Up-Regulated
Protein by End-Use - Percentage Breakdown of Value Sales for
Diagnostic Labs, Outpatient Clinics, Hospitals and Research
Centers for the Years 2012, 2021 & 2027

UNITED ARAB EMIRATES
Table 107: UAE Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 108: UAE Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 109: UAE 15-Year Perspective for Up-Regulated Protein by
End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

REST OF MIDDLE EAST
Table 110: Rest of Middle East Recent Past, Current & Future
Analysis for Up-Regulated Protein by End-Use - Diagnostic Labs,
Outpatient Clinics, Hospitals and Research Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 111: Rest of Middle East Historic Review for Up-Regulated
Protein by End-Use - Diagnostic Labs, Outpatient Clinics,
Hospitals and Research Centers Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 112: Rest of Middle East 15-Year Perspective for
Up-Regulated Protein by End-Use - Percentage Breakdown of Value
Sales for Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers for the Years 2012, 2021 & 2027

AFRICA
Up-Regulated Protein Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Africa for 2022 (E)
Table 113: Africa Recent Past, Current & Future Analysis for
Up-Regulated Protein by End-Use - Diagnostic Labs, Outpatient
Clinics, Hospitals and Research Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 114: Africa Historic Review for Up-Regulated Protein by
End-Use - Diagnostic Labs, Outpatient Clinics, Hospitals and
Research Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 115: Africa 15-Year Perspective for Up-Regulated Protein
by End-Use - Percentage Breakdown of Value Sales for Diagnostic
Labs, Outpatient Clinics, Hospitals and Research Centers for
the Years 2012, 2021 & 2027

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06033198/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001